Sunway Healthcare Group

What Sunway Healthcare Group does

Sunway Healthcare Group is the healthcare arm of Malaysian conglomerate Sunway Group (Sunway Bhd) and operates an integrated private healthcare network across Malaysia. The group runs five operating hospitals — Sunway Medical Centre Sunway City (a quaternary flagship with 28 Centres of Excellence), Velocity, Penang, Damansara, and Ipoh — with three additional hospitals in development (Putrajaya, Seremban Sentral, and a 401-bed facility in Iskandar Puteri Johor) targeting 8 hospitals and 3,400 licensed beds by 2032. The network delivers care through 28 Centres of Excellence spanning over 80 subspecialties, complemented by specialist centres (fertility, oncology, specialist outpatient) and supportive care services (TCM, home healthcare, senior living). The company serves over one million patients annually with a workforce of 710+ specialist consultants, 3,500 nurses, and 1,200 other healthcare professionals.

Sunway Healthcare monetises hospital services, medical tourism, supportive care, and clinical research. Foreign patient revenue grew 38% to RM304.7 million in FY2025, driven by international patient centres in Indonesia, China, and Cambodia. Clinical research revenue is generated through 65+ industry-sponsored projects and 100+ investigator-led studies, supported by partnerships with Syneos Health and Malaysia's NIH for Phase 1 trials. Technology is delivered through third-party advanced medical systems including DaVinci Xi robotics, Siemens NAEOTOM Alpha photon-counting CT, Stryker Mako SmartRobotics, AiBLE Spine Solution, and Malaysia's first laboratory automation system. The company is distinguished by a build-from-scratch capital model at ~RM1.5 million per bed versus ~RM6 million per bed for acquisitions, and is the first hospital in Malaysia with three hospital-wide international accreditations (JCI, ACHS, MSQH).

Following its March 2026 IPO on Bursa Malaysia — Malaysia's largest in nine years at RM2.86 billion raised — the company reports FY2025 revenue of RM2.20 billion (19% YoY growth) and net profit of RM252.2 million. Post-IPO market capitalisation reached RM26.34 billion, with shares climbing ~60% from RM1.45 to RM2.29. Cornerstone investors include AIA Malaysia, EPF, JPMorgan Asset Management, Eastspring Investments, and RBC Global Asset Management, with GIC retaining a 7.5% stake post-dilution. Revenue mix is dominated by domestic Malaysian private patients with a growing medical tourism tail and a B2B clinical research layer serving pharmaceutical clients.

Name

Sunway Healthcare Group

Legal name

Sunway Healthcare Holdings Berhad

Website

https://sunwayhealthcaregroup.com

Company type

Public

Founded year

2026

Operating status

Ipo

Headcount range

1,001–5,000 employees

Short description

Sunway Healthcare Group is a Malaysian private hospital network operating five hospitals and 28 Centres of Excellence, serving over one million patients annually across domestic and medical tourism segments, with FY2025 revenue of RM2.20 billion. Listed on Bursa Malaysia in March 2026, it is the healthcare arm of Sunway Group.

Ownership category

akta.pro rank

Product category

Private Hospital Services

NAICS

General Medical and Surgical Hospitals (6221)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Hospital-Owned Physician Networks & Medical Groups (HLAFAAAL)

akta.pro secondary industries

Palliative Care (Home-Based) Providers (HLAFAEAD), Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Private hospital services
• Medical tourism
• Tertiary healthcare
• Clinical research
• Senior living

Headquarters

HQ city

Petaling Jaya

HQ country

Malaysia

HQ region

Asia

Offices10 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Hospital Services Revenue: Revenue from quaternary and tertiary hospital services including diagnostics, treatments, surgeries, and inpatient/outpatient care across 5 operating hospitals
2. Medical Tourism: International patient services attracting visitors from Indonesia, China, and Cambodia; foreign patient revenue surged 38% to RM304.7 million in FY2025
3. Supportive Care Services: Revenue from Sunway TCM Centre, Sunway Home Healthcare, Sunway Sanctuary senior living, and fertility centres
4. Clinical Research Services: Revenue from conducting clinical trials for pharmaceutical companies across various therapeutic areas including oncology, haematology, dermatology, nephrology, rheumatology and infectious diseases

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Sunway Healthcare Group operates a network of private tertiary and quaternary hospitals in Malaysia, led by flagship Sunway Medical Centre in Sunway City with 28 Centres of Excellence spanning over 80 medical subspecialties. The group also runs complementary services including fertility, oncology, Traditional Chinese Medicine, hospital-grade home healthcare, senior living, and a clinical research centre conducting Phase 2-4 trials with Phase 1 capability under development.

Product overview

Sunway Healthcare Group operates as an integrated private healthcare network of hospitals and complementary care facilities across Malaysia. The core portfolio consists of five operating hospitals (Sunway Medical Centre Sunway City as the quaternary flagship, plus Sunway Medical Centre Velocity, Penang, Damansara, and Ipoh as tertiary/community hospitals) with three additional hospitals in development (Putrajaya, Seremban, and Iskandar Puteri Johor). The network delivers care through 28 Centres of Excellence spanning over 80 medical subspecialties, supported by specialist centres (Sunway Fertility Centre, Sunway Cancer Centre, Sunway Specialist Centre Damansara) and supportive care services (Sunway TCM Centre, Sunway Home Healthcare, Sunway Sanctuary). The group employs over 710 specialist consultants, 3,500 nurses, and 1,200 other healthcare professionals, serving over one million patients annually. It is building from scratch to operate 8 hospitals with over 3,400 licensed beds by 2032, and listed on Bursa Malaysia in March 2026 raising RM2.86 billion in Malaysia's largest IPO in nine years.

Differentiator

Problem solved

Functional benefit

Brands

• Sunway Medical Centre: Flagship quaternary hospital brand with multiple locations including Sunway City, Velocity, Penang, Damansara, and Ipoh
• Sunway TCM Centre
• Sunway Home Healthcare
• Sunway Sanctuary
• Sunway Fertility Centre
• Sunway Specialist Centre Damansara
• Sunway Clinical Research Centre

Products and services

• Sunway Medical Centre, Sunway City Flagship quaternary hospital serving as the main referral centre, housing 28 Centres of Excellence and over 80 medical subspecialties; the largest facility in the network and the top-ranked hospital in Malaysia per Newsweek's World's Best Hospitals 2026.
• Sunway Medical Centre Velocity Tertiary hospital in the Klang Valley providing a broad range of medical and surgical services, serving as a key community hospital within the network.
• Sunway Medical Centre Penang Tertiary hospital in Penang serving the northern region of Peninsular Malaysia, with a newly launched cancer centre.
• Sunway Medical Centre Damansara Tertiary hospital in Damansara serving the Klang Valley suburban community, positioned as a neighbourhood hospital.
• Sunway Medical Centre Ipoh Tertiary hospital in Ipoh serving the Perak state region, equipped with advanced robotic surgical systems including the first MAKO robotic machine in Perak.
• Sunway Fertility Centre Specialised fertility centre offering reproductive treatments and services, with locations in Kuching (Sarawak) and Kota Bharu, accredited by the Reproductive Technology Accreditation Committee.
• Sunway Cancer Centre Dedicated oncology centre providing comprehensive cancer diagnosis and treatment services including radiotherapy (Varian TrueBeam STx, Gamma Knife ICON, Accuray Radixact X9 tomotherapy, Zeiss INTRABEAM IORT), chemotherapy, and surgical oncology.
• Sunway TCM Centre Traditional and Complementary Medicine centre offering TCM services at Sunway City and Kuching, including acupuncture and TCM-based wellness programmes; winner of Patient Care Initiative of the Year and Health and Wellness Initiative of the Year awards.
• Sunway Home Healthcare Hospital-grade home healthcare service enabling patients to receive medical care at home, part of the integrated care model from home to hospital and hospital to home; winner of Home-care Initiative of the Year award.
• Sunway Sanctuary Senior living residence offering active ageing and eldercare services, with multiple Eldercare Innovation Awards for Facility of the Year Active Ageing, Operator of the Year Senior Living, and Innovation of the Year.
• Sunway Specialist Centre Damansara Ambulatory care centre in Damansara providing specialist outpatient services as part of the network's community-accessible care footprint.
• Sunway Clinical Research Centre (SCRC) Clinical research division established in 2009 conducting industry-sponsored and investigator-led clinical trials across oncology, haematology, dermatology, nephrology, rheumatology, neurology, infectious diseases, and cardiology; partnered with Syneos Health Catalyst program and signed MoU with NIH for Phase 1 trials.
• International Patient Centre / Medical Tourism Dedicated international patient centre serving medical tourists, with international representative offices and inbound patient visits from Indonesia, China, Cambodia, and other countries; foreign patient revenue reached RM304.7 million, up 38% in FY2025.

Quantifiable outcome

• 19% revenue growth to RM2.20 billion in FY2025
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered core, minor and major.

• National Institutes of Health (NIH) MalaysiacoreStrategic or Co-development Partner · 13 May 2025Malaysia's first public-private initiative for clinical research, led by Sunway Clinical Research Centre and Institute for Clinical Research. Aims to enhance Malaysia's capabilities in conducting Phase 1 clinical trials and foster collaborative ecosystem for medical research, bridging public and private healthcare efforts.
• Ministry of Health MalaysiacoreStrategic or Co-development Partner · 13 May 2025Government partnership through NIH MoU for advancing clinical research capabilities in Malaysia, positioning the country as a regional leader in early-phase research.
• Syneos HealthcoreStrategic or Co-development Partner · 26 November 2024First private hospital network in Malaysia to join Syneos Health's Catalyst and Site Network Partnerships program, providing access to improved patient recruitment, specialised expertise, greater efficiencies, and diverse patient populations across therapeutic areas and phases of clinical studies. Partnership connects Sunway to over 110 clinical sites and 60 commercial site networks worldwide.
• Clinical Research MalaysiaminorStrategic or Co-development Partner · 26 August 2024Collaboration for nationwide 'I AM AWARE' campaign and Clinical Trial Awareness Day to educate public about clinical trials and medical research participation.
• Harvard Medical SchoolmajorStrategic or Co-development PartnerAcademic partnership for clinical training, knowledge exchange, and medical education collaboration.
• University of CambridgemajorStrategic or Co-development PartnerAcademic partnership for clinical training, knowledge exchange, and research collaboration.
• Royal College of PhysiciansmajorStrategic or Co-development PartnerAcademic partnership for medical education and professional development collaboration.
• Royal Papworth HospitalmajorStrategic or Co-development PartnerInternational medical institution partnership for clinical training and knowledge exchange.
• Malaysian Healthcare Tourism Council (MHTC)minorChannel Partner/ Reseller/ DistributorGovernment-supported channel partner for promoting Malaysia as a medical tourism destination internationally.

Scale indicators12 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Fortis Healthcare: India-based multi-specialty private hospital chain. Comparable to Sunway in business model (tertiary hospitals plus diagnostics and day-care), though operating in a different market with different regulatory dynamics.
• Raffles Medical Group: Singapore-based integrated private healthcare provider with hospital and clinic operations across Asia. Comparable to Sunway for the integrated hospital-plus-clinics model and medical tourism, particularly with Sunway's Iskandar Puteri hospital targeting Singapore overflow demand.
• Bangkok Dusit Medical Services (BDMS): Thailand's largest private hospital network and a regional medical tourism leader. Comparable to Sunway for tertiary/quaternary care orientation and regional medical tourism flows, though Sunway is meaningfully smaller and focused on Malaysia rather than pan-Asia.
• Apollo Hospitals Enterprise: One of Asia's largest private hospital chains headquartered in India. Comparable as a multi-specialty tertiary private hospital operator with strong technology investment and clinical research orientation, though operating in a different geography and at a larger scale.

Direct peers

• KPJ Healthcare: Malaysia's second-largest private hospital network with 29+ hospitals across the country. Directly comparable to Sunway as a domestic multi-specialty private hospital chain competing for the same Malaysian private-pay patient base.
• Ramsay Sime Darby Health Care: Operates private hospitals in Malaysia and Indonesia under the Ramsay Sime Darby brand. Comparable to Sunway as a regional multi-specialty private hospital operator with cross-border patient flows between Malaysia and Indonesia.
• IHH Healthcare: Largest private hospital operator in Malaysia and broader Asia, operating Pantai and Gleneagles hospitals in Malaysia plus Mount Elizabeth in Singapore. Most directly comparable to Sunway given overlapping Malaysian footprint, multi-specialty tertiary care model, and medical tourism orientation toward Indonesia and Southeast Asia.
• IHH's Pantai Holdings: The Pantai brand within IHH Healthcare operates multiple tertiary hospitals across Malaysia competing directly with Sunway Medical Centre locations in the Klang Valley, Penang, and other major Malaysian cities.

Regional players

• Siloam International Hospitals: Indonesia's largest private hospital network. Comparable to Sunway as a regional multi-specialty private hospital group, particularly relevant given Sunway's Indonesia-sourced medical tourism patients and potential for cross-border expansion.
• Mitra Keluarga Karyasehat: Indonesian private hospital group with a network of 30+ hospitals focused on the mid-market segment. Relevant regional comparable given the strong Indonesia medical tourism flow into Sunway, though operating primarily within Indonesia rather than serving outbound medical tourists.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/sunwayhealthcaregroup
• LinkedInlinkedin.com/company/sunwayhealthcaregroup

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sunway Healthcare Group